With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.494769-34-5,N-Boc-2-Amino-4-formylthiazole,as a common compound, the synthetic route is as follows.
TFA (2.0 mL) was added to a 0 C. solution of Part A compound (0.64 g; 2.80 mmol) in DCM (4.0 mL). After 20 h at RT the reaction mixture was concentrated in vacuo. The residue was partitioned between EtOAc (10 mL) and sat. aqueous NaHCO3 (8 mL). The aqueous phase was isolated and extracted with EtOAc (5×8 mL). The combined organic extracts were dried (MgSO4) and concentrated in vacuo to give Part B compound (0.30 g; 83%) as a yellow solid., 494769-34-5
As the paragraph descriping shows that 494769-34-5 is playing an increasingly important role.
Reference：
Patent; Bristol-Myers Squibb Company; US2008/9465; (2008); A1;,
Thiazole | C3H3NS – PubChem
Thiazole | chemical compound | Britannica